Researchers shed light on new multiple myeloma therapy
05:00 EDT 25 Jul 2012 | Medical Xpress
Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer..
Original Article: Researchers shed light on new multiple myeloma therapy
More From BioPortfolio on "Researchers shed light on new multiple myeloma therapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
